Follow The Filings

CPRT Copart

Copart earnings company data as of 4:48 AM ET 10/22

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q4 19 Nov EPS 0.41 — —
Rev — — —
FY2026 Q4 10 Sep EPS 0.39 — —
Rev — $27.3M —

Insider trades

Open-market buys and sales by CPRT's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CPRT insider trades
  • None no insider bought on the open market
  • $8.5M sold by 4 insiders outside a trading plan
  • $846K sold by 1 insider under 10b5-1 plans
  1. Diane M Morefield Director
    Sale
    $553K 20,000 shares at $27.66 29% of stake
    Traded Oct 15 Filed Oct 19
  2. Jeffrey Liaw CEO
    Planned sale
    $846K 27,745 shares at $30.49 22% of stake
    Traded Jul 28 Filed Jul 30
  3. Daniel J Englander Director
    Sale
    $2.2M 80,000 shares at $27.55 23% of stake
    Traded Jul 13 Filed Jul 15
  4. Jeffrey Liaw CEO
    Sale
    $870K 26,213 shares at $33.18 25% of stake
    Traded Apr 15 Filed Apr 17
  5. Jeffrey Liaw CEO
    Sale
    $1M 25,137 shares at $40.17 31% of stake
    Traded Jan 15 Filed Jan 16
  6. Thomas N Tryforos Director
    Sale
    $3.9M 100,000 shares at $39.07 100% of stake
    Traded Nov 25, 2025 Filed Nov 25, 2025
  7. Jeffrey Liaw CEO
    Sale
    $1.1M 24,283 shares at $44.79 44% of stake
    Traded Oct 15, 2025 Filed Oct 17, 2025

Also filed in the last 12 months, not counted as buying or selling: 15 option exercises, 6 gifts, and 4 other transactions.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
DEF 14A
DEFA14A
8-K 5.02,9.01
8-K 2.01,7.01,9.01
10-K
8-K 1.01,7.01,9.01
8-K 2.02,9.01
8-K/A 5.02
8-K 5.02,7.01,9.01
8-K 5.02,7.01,9.01
8-K 5.02,7.01,9.01
10-Q
8-K 2.02,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 1.01,2.03,9.01
8-K 5.07

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.